Our partners

About Us

Determined to be a Pioneer in Mitochondrial Medical Technology

History

In 2012, Mitomed developed an interest in mitochondrial medicine and began conducting research, as mitochondria may hold the key to cellular aging and regeneration. Subsequent studies revealed that the principle behind stem cell therapy also stems from mitochondrial transfer. Mitomed later founded a company to continue researching and developing related mitochondrial medical technologies. To date, it has created multiple technology platforms applicable to cell therapy, neural repair, pharmaceuticals, and anti-aging. Mitomed takes pride in being a pioneer in mitochondrial medicine worldwide.

Achievements

  • Confirmed the relationship between mitochondria and cellular repair
  • Mitochondria-enhancing agent technology platform MitoMedium
  • Mitochondria-enhanced stem cell technology MitoSC
  • Mitochondrial formulation technology MitoCure
  • Developed multiple candidate compounds for mitochondrial activation drugs

Vision

Aspire to be a pioneer in mitochondrial medical technology

Mission

  • Develop mitochondrial medical technologies to treat cellular damage and degenerative diseases
  • Advance new regenerative medical technologies for all humankind

Values

Integrity · Innovation · Humanity